| PG |
Report |
Q4 core EPS |
IN-LINE |
pred ~$1.41 vs. cons $1.407 |
MEDIUM |
| PG |
Report |
Q4 organic sales growth |
MISS |
pred ~1.50% vs. cons 1.62% |
MEDIUM |
| PG |
Report |
Q4 volume growth |
MISS |
pred ~0.50% vs. cons 0.55% |
MEDIUM |
| PG |
Guide |
FY27 organic sales growth |
LOWER |
guide ~2.0% vs. cons 2.46% |
LOW |
| PG |
Guide |
FY27 core EPS |
UNCHANGED |
guide ~$7.00 vs. cons $7.00 |
LOW |
| PG |
Guide |
FY27 U.S. demand / cost commentary |
LOWER |
continued value pressure and persistent cost mitigation needs |
LOW |
| PG |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
LOW |
| PG |
Return |
5-day cumulative residual |
-2.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — lower FY27 top-line setup should pull revisions lower |
LOW |